- Previous Close
1.3700 - Open
1.3500 - Bid --
- Ask --
- Day's Range
1.3300 - 1.4000 - 52 Week Range
1.1700 - 3.7200 - Volume
8,225 - Avg. Volume
19,475 - Market Cap (intraday)
62.726M - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
www.intercure.co270
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: INCR
View MorePerformance Overview: INCR
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INCR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INCR
View MoreValuation Measures
Market Cap
64.85M
Enterprise Value
99.86M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.87
Price/Book (mrq)
0.52
Enterprise Value/Revenue
1.37
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-24.07%
Return on Assets (ttm)
-0.23%
Return on Equity (ttm)
-13.61%
Revenue (ttm)
272.67M
Net Income Avi to Common (ttm)
-65.62M
Diluted EPS (ttm)
-0.3900
Balance Sheet and Cash Flow
Total Cash (mrq)
20.3M
Total Debt/Equity (mrq)
32.63%
Levered Free Cash Flow (ttm)
--